Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women

Julie A. Dumas, Andrew Saykin, Brenna McDonald, Thomas W. McAllister, Mary L. Hynes, Paul A. Newhouse

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objectives: An important aspect of furthering our understanding of the central nervous system function after menopause is to examine the cerebral circuitry that appears to be influenced by cholinergic antagonist drugs in the presence and absence of estrogen. This pilot study investigated the effects of two anticholinergic drugs on brain activation and working memory performance in postmenopausal women not taking estrogen. This approach simulates the effects of age- or disease-related neuroreceptor or neuronal loss by temporarily blocking pre- and postsynaptic muscarinic and nicotinic cholinergic receptors. Design: Six healthy postmenopausal women took part in three drug challenges using the antinicotinic drug mecamylamine (MECA, 20 mg, oral), the antimuscarinic drug scopolamine (SCOP, 2.5 g/kg, IV), and placebo during functional magnetic resonance imaging. The cognitive measure was a visually presented verbal N-back test of working memory. Results: Neither MECA nor SCOP significantly impaired performance on the verbal N-back. Functional magnetic resonance imaging results showed greater increases in frontal lobe activation in the placebo condition relative to each drug condition with different specific regional activation for MECA and SCOP. Conclusions: These preliminary results suggest that brain activation patterns are sensitive to cholinergic modulation in postmenopausal women and that differential effects may be observed following nicotinic versus muscarinic blockade. This approach offers a potentially valuable method for modeling age-related changes in brain function, and the findings may have implications for cholinergic contributions to normal and pathologic aging.

Original languageEnglish
Pages (from-to)272-282
Number of pages11
JournalAmerican Journal of Geriatric Psychiatry
Volume16
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Short-Term Memory
Cholinergic Agents
Brain
Pharmaceutical Preparations
Cholinergic Antagonists
Estrogens
Placebos
Magnetic Resonance Imaging
Mecamylamine
Muscarinic Antagonists
Scopolamine Hydrobromide
Nicotinic Receptors
Frontal Lobe
Cholinergic Receptors
Sensory Receptor Cells
Menopause
Central Nervous System
5'-N-methylcarboxamideadenosine

Keywords

  • Cholinergic system
  • FMRI
  • Postmenopausal women
  • Working memory

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. / Dumas, Julie A.; Saykin, Andrew; McDonald, Brenna; McAllister, Thomas W.; Hynes, Mary L.; Newhouse, Paul A.

In: American Journal of Geriatric Psychiatry, Vol. 16, No. 4, 04.2008, p. 272-282.

Research output: Contribution to journalArticle

Dumas, Julie A. ; Saykin, Andrew ; McDonald, Brenna ; McAllister, Thomas W. ; Hynes, Mary L. ; Newhouse, Paul A. / Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. In: American Journal of Geriatric Psychiatry. 2008 ; Vol. 16, No. 4. pp. 272-282.
@article{7c66ba26da6c430f82e9db5a6022f294,
title = "Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women",
abstract = "Objectives: An important aspect of furthering our understanding of the central nervous system function after menopause is to examine the cerebral circuitry that appears to be influenced by cholinergic antagonist drugs in the presence and absence of estrogen. This pilot study investigated the effects of two anticholinergic drugs on brain activation and working memory performance in postmenopausal women not taking estrogen. This approach simulates the effects of age- or disease-related neuroreceptor or neuronal loss by temporarily blocking pre- and postsynaptic muscarinic and nicotinic cholinergic receptors. Design: Six healthy postmenopausal women took part in three drug challenges using the antinicotinic drug mecamylamine (MECA, 20 mg, oral), the antimuscarinic drug scopolamine (SCOP, 2.5 g/kg, IV), and placebo during functional magnetic resonance imaging. The cognitive measure was a visually presented verbal N-back test of working memory. Results: Neither MECA nor SCOP significantly impaired performance on the verbal N-back. Functional magnetic resonance imaging results showed greater increases in frontal lobe activation in the placebo condition relative to each drug condition with different specific regional activation for MECA and SCOP. Conclusions: These preliminary results suggest that brain activation patterns are sensitive to cholinergic modulation in postmenopausal women and that differential effects may be observed following nicotinic versus muscarinic blockade. This approach offers a potentially valuable method for modeling age-related changes in brain function, and the findings may have implications for cholinergic contributions to normal and pathologic aging.",
keywords = "Cholinergic system, FMRI, Postmenopausal women, Working memory",
author = "Dumas, {Julie A.} and Andrew Saykin and Brenna McDonald and McAllister, {Thomas W.} and Hynes, {Mary L.} and Newhouse, {Paul A.}",
year = "2008",
month = "4",
doi = "10.1097/JGP.0b013e3181602a2b",
language = "English",
volume = "16",
pages = "272--282",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women

AU - Dumas, Julie A.

AU - Saykin, Andrew

AU - McDonald, Brenna

AU - McAllister, Thomas W.

AU - Hynes, Mary L.

AU - Newhouse, Paul A.

PY - 2008/4

Y1 - 2008/4

N2 - Objectives: An important aspect of furthering our understanding of the central nervous system function after menopause is to examine the cerebral circuitry that appears to be influenced by cholinergic antagonist drugs in the presence and absence of estrogen. This pilot study investigated the effects of two anticholinergic drugs on brain activation and working memory performance in postmenopausal women not taking estrogen. This approach simulates the effects of age- or disease-related neuroreceptor or neuronal loss by temporarily blocking pre- and postsynaptic muscarinic and nicotinic cholinergic receptors. Design: Six healthy postmenopausal women took part in three drug challenges using the antinicotinic drug mecamylamine (MECA, 20 mg, oral), the antimuscarinic drug scopolamine (SCOP, 2.5 g/kg, IV), and placebo during functional magnetic resonance imaging. The cognitive measure was a visually presented verbal N-back test of working memory. Results: Neither MECA nor SCOP significantly impaired performance on the verbal N-back. Functional magnetic resonance imaging results showed greater increases in frontal lobe activation in the placebo condition relative to each drug condition with different specific regional activation for MECA and SCOP. Conclusions: These preliminary results suggest that brain activation patterns are sensitive to cholinergic modulation in postmenopausal women and that differential effects may be observed following nicotinic versus muscarinic blockade. This approach offers a potentially valuable method for modeling age-related changes in brain function, and the findings may have implications for cholinergic contributions to normal and pathologic aging.

AB - Objectives: An important aspect of furthering our understanding of the central nervous system function after menopause is to examine the cerebral circuitry that appears to be influenced by cholinergic antagonist drugs in the presence and absence of estrogen. This pilot study investigated the effects of two anticholinergic drugs on brain activation and working memory performance in postmenopausal women not taking estrogen. This approach simulates the effects of age- or disease-related neuroreceptor or neuronal loss by temporarily blocking pre- and postsynaptic muscarinic and nicotinic cholinergic receptors. Design: Six healthy postmenopausal women took part in three drug challenges using the antinicotinic drug mecamylamine (MECA, 20 mg, oral), the antimuscarinic drug scopolamine (SCOP, 2.5 g/kg, IV), and placebo during functional magnetic resonance imaging. The cognitive measure was a visually presented verbal N-back test of working memory. Results: Neither MECA nor SCOP significantly impaired performance on the verbal N-back. Functional magnetic resonance imaging results showed greater increases in frontal lobe activation in the placebo condition relative to each drug condition with different specific regional activation for MECA and SCOP. Conclusions: These preliminary results suggest that brain activation patterns are sensitive to cholinergic modulation in postmenopausal women and that differential effects may be observed following nicotinic versus muscarinic blockade. This approach offers a potentially valuable method for modeling age-related changes in brain function, and the findings may have implications for cholinergic contributions to normal and pathologic aging.

KW - Cholinergic system

KW - FMRI

KW - Postmenopausal women

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=48649093082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48649093082&partnerID=8YFLogxK

U2 - 10.1097/JGP.0b013e3181602a2b

DO - 10.1097/JGP.0b013e3181602a2b

M3 - Article

C2 - 18378552

AN - SCOPUS:48649093082

VL - 16

SP - 272

EP - 282

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 4

ER -